Helix Partners Exits Sallie Mae Position as Student Loan Servicer Faces Credit Headwinds

The Motley FoolThe Motley Fool
|||1 min read
Key Takeaway

Helix Partners exits entire Sallie Mae stake amid rising loan delinquencies and credit headwinds at the student loan servicer, which underperformed the market by 27.5 percentage points.

Helix Partners Exits Sallie Mae Position as Student Loan Servicer Faces Credit Headwinds

Helix Partners Management LP has liquidated its entire stake in SLM Corporation, selling 200,000 shares for approximately $5.54 million during the fourth quarter. The divestment occurs as Sallie Mae's stock has underperformed significantly, declining 14.6% over the past 12 months compared to a 13% gain in the S&P 500, representing a 27.5 percentage point gap in relative performance.

The fund's exit coincides with emerging credit challenges at the student loan servicer. SLM reported loan delinquencies rising to 4.0% and provided guidance indicating increased net charge-offs anticipated for 2026, suggesting a normalization of credit conditions following the extended federal student loan payment moratorium. These metrics contrast with the company's otherwise solid operational performance, which included $3.46 in GAAP diluted earnings per share in recent results.

Despite these headwinds, Sallie Mae's board authorized a $500 million share repurchase program, indicating management confidence in the company's long-term value. However, rising credit stress and elevated delinquency rates may limit stock appreciation near term as investors assess the trajectory of loan performance in a higher-rate environment.

Source: The Motley Fool

Back to newsPublished Feb 14

Related Coverage

GlobeNewswire Inc.

POET Technologies Hit with Securities Fraud Lawsuit Over PFIC Disclosure Failures

Kirby McInerney LLP files class action against POET Technologies for alleged securities fraud involving PFIC misrepresentation and confidentiality breaches, triggering steep stock declines.

POET
GlobeNewswire Inc.

ImmunityBio Stock Plummets 21% After FDA Warning Over Anktiva Cancer Claims

ImmunityBio faces securities fraud lawsuit after FDA warning letter alleges false Anktiva promotional claims. Stock dropped 21% to $7.42.

IBRX
Benzinga

Johnson Outdoors Beats Earnings But Cost Pressures Weigh on Stock

Johnson Outdoors delivered strong Q2 results with 16% sales growth and margin expansion, but flagged mounting cost pressures and inventory challenges, causing shares to decline.

JOUT
The Motley Fool

MercadoLibre Stock Plunges 11% Despite Revenue Beat and Strong Cash Flow

MercadoLibre shares fell 11% after Q1 earnings beat revenue expectations but missed profit forecasts, as the company invests heavily in growth. Free cash flow doubled to $1.8B, trading at attractive 7.1x FCF multiple.

MELI
GlobeNewswire Inc.

Shell Launches $3B Buyback as Energy Giant Returns Cash to Shareholders

Shell initiates $3 billion share repurchase program managed by Goldman Sachs through July 2026, alongside Q1 dividend announcement.

SHEL
GlobeNewswire Inc.

Bekaert Accelerates €75M Buyback, Repurchases 33K Shares in Single Week

Belgian steelmaker Bekaert repurchased 33,244 shares at €42.56 average price as part of €75M buyback program, holding 3.79% of outstanding shares.

BEKAY